Project Grant DP2HG014282

Award Date 9/19/24
Completion Date 8/31/27
Dollars Obligated $2.6M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award for $378,123 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to identify and test mechanisms that establish transcriptional regulatory potency in early embryos. The primary activities include using genomic methods like PRO-seq, DREG, and OMNI-ATAC to characterize transcriptionally active regulatory elements, DNA accessibility, and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $393,093 to The Trustees of Columbia University in the City of New York to uncover the interplay between gene expression, cell morphometrics, and tissue-level mechanics during embryonic development. The research aims to develop an integrative, statistical machine learning framework for 4D mammalian development, leveraging...
This Project Grant award of $125,000 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to map cell state and lineage during early mouse development. The awardee, the Whitehead Institute for Biomedical Research, will leverage a novel prime editing-based technology called PETRACER to conduct integrated, spatially-resolved analyses of progenitor...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
The National Institute of General Medical Sciences (NIGMS) awarded a $508,315 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of California, San Diego (UCSD) to investigate the molecular mechanisms required for successful developmental progression from oocyte to embryo during a critical window of transcriptional silence in mammals. The overarching goal is to uncover post-transcriptional regulatory mechanisms, such as mRNA poly(A) tail dynamics, that...
This $1,383,800 federal Project Grant award from the Department of Health and Human Services' National Institutes of Health, under the Trans-NIH Research Support (CFDA 93.310) program, supports the University of Pittsburgh's research to develop new methods for creating and testing developmental signaling patterns. The project aims to leverage high-throughput optogenetic manipulation to build libraries of paired data on developmental signaling patterns and resulting tissue structures. This...
This federal Project Grant award of $327,019 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research at the University of California, San Diego (UCSD) to develop innovative conceptual, theoretical, and computational tools to detect coherent patterns in complex nonlinear biological systems and devise mechanistic biophysical models to predict and explain these patterns. The overarching aim is to elucidate how...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA 93.859 Biomedical Research and Research Training program, provides $162,874 to The Trustees of Princeton University to conduct research on the regulation of protein dynamics in the ectoderm germ layer of Drosophila embryos. The key objectives are to: Quantify proteome differentiation and stochastic cell fate diversification using deep multiplexed proteomics and single-cell RNA sequencing (Aims...
Yale University was awarded a $3,015,000 Project Grant from the Department of Health and Human Services National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) for the period of September 15, 2022 through August 31, 2025. The grant will support research to develop a controllable and scalable in vitro model for studying human embryonic patterning and germ layer differentiation using human pluripotent stem cells and bioengineering...
The National Institutes of Health Office of the Director awarded The Trustees of Princeton University a $2,877,560 project grant under the Trans-NIH Research Support program (CFDA 93.310) to build a systematic, comprehensive mammalian cell fate map from September 1, 2022 to August 31, 2025. Leveraging single-cell RNA sequencing and CRISPR-Cas9 genome editing, Princeton University will establish an evolving lineage tracing platform capable of recording mammalian differentiation processes at...

This $2,624,970 federal Project Grant, awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), aims to construct the first-ever foundational in silico (computational) model of whole-embryo mouse embryogenesis. The project will leverage cutting-edge sequencing technology and machine learning techniques to establish a large-scale 3D multi-omics cell atlas of mouse embryogenesis from embryonic day 6.5 to 16.5, involving a total of 50 million cells. The researchers will then develop sophisticated temporal modeling and spatial transcriptomics analysis methods to integrate the temporal and spatial data dimensions, enabling the creation of a data-driven partial differential equation (PDE) model capable of accurately simulating the entire embryogenesis process. This project seeks to bridge critical gaps in the understanding of embryogenesis and has the potential to revolutionize the study of developmental biology, disease mechanisms, and therapeutic interventions. The award period runs from September 19, 2024 to August 31, 2027.

Generated 8/5/25, 4:38 AM